US FDA authorises Meridian’s revised molecular assay for Omicron variant
Meridian’s molecular diagnostic test is now authorised for the qualitative detection of the SARS-CoV-2 virus, including its Omicron…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
01 Aug 22
Meridian’s molecular diagnostic test is now authorised for the qualitative detection of the SARS-CoV-2 virus, including its Omicron…
01 Aug 22
A jury for the US District Court of Delaware has confirmed the use of Magnolia’s patented Initial Specimen…
01 Aug 22
The centre will be the first in Lille, France, to provide the Hauts de France area with advanced…
01 Aug 22
Findings from the 48-week study were recently published in the online issue of the Journal of Hepatology
01 Aug 22
Points to Accuracy Levels Comparable to Existing Standards of Care for Amyloid Diagnosis in the Evaluation of Patients…
29 Jul 22
The planned spin-off is expected to enhance the strategic and operational focus and create value for both new…
29 Jul 22
The OS Ultra scanners deliver high-resolution images that can be analysed further with the help of OptraSCAN's artificial…
28 Jul 22
Claimed to be the only SDH-specific AI-powered platform, Viz SDH is capable of identifying acute and chronic subdural…
28 Jul 22
With approval, Acutus Medical will begin a new era of non-contact imaging and diagnostics for arrhythmia care in…
28 Jul 22
Under the deal, ELITechGroup will provide contract development and manufacturing services for HypoxE IVD Tests designed for the…